Movitz C - Search Results

1

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.

Sander FE, Nilsson M, Rydström A, Aurelius J, Riise RE, Movitz C, Bernson E, Kiffin R, Ståhlberg A, Brune M, Foà R, Hellstrand K, Thorén FB, Martner A. Sander FE, et al. Among authors: movitz c. Cancer Immunol Immunother. 2017 Nov;66(11):1473-1484. doi: 10.1007/s00262-017-2040-9. Epub 2017 Jul 18. Cancer Immunol Immunother. 2017. PMID: 28721449 Free PMC article. Clinical Trial.

2

Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.

Akhiani AA, Werlenius O, Aurelius J, Movitz C, Martner A, Hellstrand K, Thorén FB. Akhiani AA, et al. Among authors: movitz c. PLoS One. 2014 Feb 21;9(2):e89646. doi: 10.1371/journal.pone.0089646. eCollection 2014. PLoS One. 2014. PMID: 24586933 Free PMC article.

3

A simple skin blister technique for the study of in vivo transmigration of human leukocytes.

Davidsson L, Björkman L, Christenson K, Alsterholm M, Movitz C, Thorén FB, Karlsson A, Welin A, Bylund J. Davidsson L, et al. Among authors: movitz c. J Immunol Methods. 2013 Jul 31;393(1-2):8-17. doi: 10.1016/j.jim.2013.03.013. Epub 2013 Apr 6. J Immunol Methods. 2013. PMID: 23570945

4

The recurrent Guillain-Barré syndrome: a long-term population-based study.

Mossberg N, Nordin M, Movitz C, Nilsson S, Hellstrand K, Bergström T, Andersson B, Andersen O. Mossberg N, et al. Among authors: movitz c. Acta Neurol Scand. 2012 Sep;126(3):154-61. doi: 10.1111/j.1600-0404.2012.01667.x. Epub 2012 Apr 17. Acta Neurol Scand. 2012. PMID: 22507178

5

A new chemiluminescence paradox: selective inhibition of isoluminol-amplified activity in phagocytes by peptides from annexin AI.

Dahlberg M, Dahlgren C, Hellstrand K, Movitz C. Dahlberg M, et al. Among authors: movitz c. Luminescence. 2008 May-Jun;23(3):139-43. doi: 10.1002/bio.1023. Luminescence. 2008. PMID: 18452130

6

Oxygen radical production in leukocytes and disease severity in multiple sclerosis.

Mossberg N, Movitz C, Hellstrand K, Bergström T, Nilsson S, Andersen O. Mossberg N, et al. Among authors: movitz c. J Neuroimmunol. 2009 Aug 18;213(1-2):131-4. doi: 10.1016/j.jneuroim.2009.05.013. Epub 2009 Jul 8. J Neuroimmunol. 2009. PMID: 19589606

7

The annexin I sequence gln(9)-ala(10)-trp(11)-phe(12) is a core structure for interaction with the formyl peptide receptor 1.

Movitz C, Brive L, Hellstrand K, Rabiet MJ, Dahlgren C. Movitz C, et al. J Biol Chem. 2010 May 7;285(19):14338-45. doi: 10.1074/jbc.M109.080465. Epub 2010 Mar 10. J Biol Chem. 2010. PMID: 20220135 Free PMC article.

8

Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome.

Mossberg N, Andersen O, Nordin M, Nilsson S, Svedhem A, Bergström T, Hellstrand K, Movitz C. Mossberg N, et al. Among authors: movitz c. J Inflamm (Lond). 2010 Aug 8;7:40. doi: 10.1186/1476-9255-7-40. J Inflamm (Lond). 2010. PMID: 20691112 Free PMC article.

9

Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.

Karlsson J, Fu H, Boulay F, Dahlgren C, Hellstrand K, Movitz C. Karlsson J, et al. Among authors: movitz c. J Leukoc Biol. 2005 Sep;78(3):762-71. doi: 10.1189/jlb.0305153. Epub 2005 Jun 10. J Leukoc Biol. 2005. PMID: 15951351

10

Oxygen radical production and severity of the Guillain--Barré syndrome.

Mossberg N, Andersen O, Nilsson S, Dahlgren C, Hellstrand K, Lindh M, Svedhem A, Bergström T, Movitz C. Mossberg N, et al. Among authors: movitz c. J Neuroimmunol. 2007 Dec;192(1-2):186-91. doi: 10.1016/j.jneuroim.2007.09.020. Epub 2007 Oct 22. J Neuroimmunol. 2007. PMID: 17945354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page